PL1768948T3 - Podstawione związki aminowe jako inhibitory wychwytu-5-HT/NA - Google Patents
Podstawione związki aminowe jako inhibitory wychwytu-5-HT/NAInfo
- Publication number
- PL1768948T3 PL1768948T3 PL05758901T PL05758901T PL1768948T3 PL 1768948 T3 PL1768948 T3 PL 1768948T3 PL 05758901 T PL05758901 T PL 05758901T PL 05758901 T PL05758901 T PL 05758901T PL 1768948 T3 PL1768948 T3 PL 1768948T3
- Authority
- PL
- Poland
- Prior art keywords
- substituted amino
- amino compounds
- uptake inhibitors
- compounds
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004034619A DE102004034619A1 (de) | 2004-07-16 | 2004-07-16 | Substituierte Aminoverbindungen als 5-HT/NA Uptakehemmer |
| PCT/EP2005/007537 WO2006008032A1 (de) | 2004-07-16 | 2005-07-12 | Substituierte aminoverbindungen als 5-ht/na uptakehemmer |
| EP05758901A EP1768948B1 (de) | 2004-07-16 | 2005-07-12 | Substituierte aminoverbindungen als 5-ht/na uptakehemmer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1768948T3 true PL1768948T3 (pl) | 2008-10-31 |
Family
ID=35064779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05758901T PL1768948T3 (pl) | 2004-07-16 | 2005-07-12 | Podstawione związki aminowe jako inhibitory wychwytu-5-HT/NA |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7342133B2 (pl) |
| EP (1) | EP1768948B1 (pl) |
| JP (1) | JP4926956B2 (pl) |
| AT (1) | ATE396169T1 (pl) |
| CA (1) | CA2573754C (pl) |
| CY (1) | CY1110436T1 (pl) |
| DE (2) | DE102004034619A1 (pl) |
| DK (1) | DK1768948T3 (pl) |
| ES (1) | ES2308514T3 (pl) |
| PL (1) | PL1768948T3 (pl) |
| PT (1) | PT1768948E (pl) |
| SI (1) | SI1768948T1 (pl) |
| WO (1) | WO2006008032A1 (pl) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1518663A1 (de) * | 1965-08-02 | 1969-12-18 | Gruenenthal Chemie | Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung |
| JPS598259B2 (ja) * | 1976-01-01 | 1984-02-23 | 武田薬品工業株式会社 | 新規シクロヘキセン誘導体 |
| US20050090553A1 (en) * | 1992-06-30 | 2005-04-28 | Shapiro Howard K. | Compositions and method for treatment of chronic inflammatory diseases |
| DE19609847A1 (de) * | 1996-03-13 | 1997-09-18 | Gruenenthal Gmbh | Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe |
| ES2141688B1 (es) * | 1998-11-06 | 2001-02-01 | Vita Invest Sa | Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos. |
| DE19857475A1 (de) * | 1998-12-14 | 2000-06-15 | Gruenenthal Gmbh | Substituierte Cycloheptene, deren Herstellung und Verwendung |
| DE19915601A1 (de) * | 1999-04-07 | 2000-10-19 | Gruenenthal Gmbh | 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung |
| DE10033459A1 (de) * | 2000-07-10 | 2002-01-24 | Gruenenthal Gmbh | Cyclische substituierte Aminomethylverbindungen und diese Verbindungen enthaltende Arzeimittel |
| DE10132747A1 (de) * | 2001-07-05 | 2003-01-23 | Gruenenthal Gmbh | Substituierte 1-Aryl-but-3-enylamin- und 1-Aryl-but-2-enylaminverbindungen |
| EP1643998B1 (en) * | 2003-07-03 | 2007-08-29 | F. Hoffmann-La Roche Ag | Dual nk1/nk3 antagonists for treating schizophrenia |
-
2004
- 2004-07-16 DE DE102004034619A patent/DE102004034619A1/de not_active Withdrawn
-
2005
- 2005-07-12 EP EP05758901A patent/EP1768948B1/de not_active Not-in-force
- 2005-07-12 DK DK05758901T patent/DK1768948T3/da active
- 2005-07-12 PL PL05758901T patent/PL1768948T3/pl unknown
- 2005-07-12 JP JP2007520735A patent/JP4926956B2/ja not_active Expired - Fee Related
- 2005-07-12 PT PT05758901T patent/PT1768948E/pt unknown
- 2005-07-12 WO PCT/EP2005/007537 patent/WO2006008032A1/de active IP Right Grant
- 2005-07-12 CA CA2573754A patent/CA2573754C/en not_active Expired - Fee Related
- 2005-07-12 AT AT05758901T patent/ATE396169T1/de active
- 2005-07-12 SI SI200530340T patent/SI1768948T1/sl unknown
- 2005-07-12 DE DE502005004207T patent/DE502005004207D1/de active Active
- 2005-07-12 ES ES05758901T patent/ES2308514T3/es active Active
-
2007
- 2007-01-16 US US11/653,222 patent/US7342133B2/en not_active Expired - Fee Related
-
2008
- 2008-08-14 CY CY20081100870T patent/CY1110436T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7342133B2 (en) | 2008-03-11 |
| PT1768948E (pt) | 2008-07-10 |
| JP4926956B2 (ja) | 2012-05-09 |
| ES2308514T3 (es) | 2008-12-01 |
| DK1768948T3 (da) | 2008-09-15 |
| US20070185212A1 (en) | 2007-08-09 |
| JP2008506645A (ja) | 2008-03-06 |
| ATE396169T1 (de) | 2008-06-15 |
| CA2573754C (en) | 2012-04-24 |
| EP1768948A1 (de) | 2007-04-04 |
| WO2006008032A1 (de) | 2006-01-26 |
| DE102004034619A1 (de) | 2006-02-23 |
| SI1768948T1 (sl) | 2008-10-31 |
| CA2573754A1 (en) | 2006-01-26 |
| EP1768948B1 (de) | 2008-05-21 |
| DE502005004207D1 (de) | 2008-07-03 |
| CY1110436T1 (el) | 2015-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008089310A3 (en) | Delta 5 desaturase inhibitors for the treatment of obesity | |
| TW200800976A (en) | New compounds for the treatment of neurological, psychiatric or pain disorders | |
| TW200633980A (en) | Pyridones useful as inhibitors of kinases | |
| TW200514776A (en) | Aminotriazole compounds useful as inhibitors of protein kinases | |
| WO2008089307A3 (en) | Delta 5 desaturase inhibitors for the treatment of pain, inflammation and cancer | |
| TW200531689A (en) | Therapeutic agents | |
| TW200630090A (en) | Triazoles useful as inhibitors of protein kinases | |
| TNSN07111A1 (en) | Preparation and use of biphenyl-4-yl- carbonylamino acid derivatives for the treatment of obesity. | |
| IL181987A0 (en) | Diaminotriazole derivatives and pharmaceutical compositions containing the same | |
| IL196543A (en) | Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders | |
| HK1096673A1 (en) | Compositions useful as inhibitors of protein kinases | |
| TNSN07093A1 (en) | Bicyclic amides as kinase inhibitors | |
| ZA200901037B (en) | Pyrimidone compounds as GSK-3 inhibitors | |
| TW200602052A (en) | Azaindoles useful as inhibitors of JAK and other protein kinases | |
| IL200793A0 (en) | Aminopyrimidines, compositions comprising the same and use thereof for inhibiting protein kinases | |
| MX2007011545A (es) | Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr. | |
| MX2009006345A (es) | Compuestos utiles como inhibidores de proteina cinasa. | |
| TW200633986A (en) | Therapeutic agents | |
| TW200716091A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
| BRPI0506970A (pt) | derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior | |
| EA200800011A1 (ru) | Тиенопиримидиновые и тиенопиридиновые модуляторы киназы | |
| IL179206A0 (en) | Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same | |
| TW200740808A (en) | Inhibiteurs de proteines kinases | |
| TW200621773A (en) | Bicyclononene derivatives | |
| TW200728300A (en) | Therapeutic agents |